My Take My take is that if LFB stays the course and continues development and commits to a larger Phase 2b or Phase 3 (even better) this is a huge opportunity to buy more stock. If they bail on the program this goes straight into the toilet. Time will tell. All depends on whether they are surprised by the lack of efficacy signal, or whether they knew it was underpowered and hoped for but didn't expect anything different.